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a b s t r a c t
Anew antimicrobial peptide, herein named Stigmurin, was selected based on a transcriptomic analysis of
the Brazilian yellow scorpion Tityus stigmurus venom gland, an underexplored source for toxic peptides
with possible biotechnological applications. Stigmurin was investigated in silico, by circular dichroism
(CD) spectroscopy, and in vitro. The CD spectra suggested that this peptide interacts with membranes,
changing its conformation in thepresenceof anamphipathic environment,withpredominanceof random
coil and beta-sheet structures. Stigmurin exhibited antibacterial and antifungal activity, with minimaleywords:
corpion venom
ityus stigmurus
ntimicrobial peptide (AMP)
on-disulﬁde-bridged peptide (NDBP)
mphipathic peptide
ircular dichroism (CD)
inhibitory concentrations ranging from 8.7 to 69.5M. It was also showed that Stigmurin is toxic against
SiHa and Vero E6 cell lines. The results suggest that Stigmurin can be considered a potential anti-infective
drug.
© 2015 Elsevier Inc. All rights reserved.ntroduction
Antimicrobial peptides (AMPs) are important components of
he innate immune system, showing a broad spectrum of action
gainstmicrobes [33,40]. It is believed that themechanismof action
f these peptides is not dependent on interaction with a speciﬁc
eceptor, making them interesting therapeutic alternatives when
ompared to available antibiotics; the latter act mainly by inhibit-
ng biosynthetic pathways and are more prone to induce microbial
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aceˆutica, Universidade Federal do Rio Grande do Norte, RN, Brazil.
el.: +55 84 3342 9820; fax: +55 84 3342 9833.
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1 Both authors contributed equally to this work.
ttp://dx.doi.org/10.1016/j.peptides.2015.03.003
196-9781/© 2015 Elsevier Inc. All rights reserved.resistance [32,54,85]. AMPs are distributed across a wide vari-
ety of species, including unicellular microorganisms, invertebrates
and vertebrates, which strongly suggests the importance of these
molecules in the process of survival [48,66].
The presence of AMPs in the venom of scorpions is fre-
quently reported in the literature as an early evolved primitive
componentof the immunesystem[1,56]. Someexamplesof antimi-
crobial peptides found in scorpion venom include Hadrurin from
Hadrurus aztecus [75], Opistoporins from Opistophtalmus carinatus
[50], Parabutoporin from Parabuthus schlechteri [76], IsCTs from
Opisthacanthus madagascariensis [18,19], Pandinins from Pand-
inus imperator [15], Mucroporin from Lychas mucronatus [17],
Imcroporin from Isometrus maculatus [88], VmCt1, VmCt2 and
Vejovine from Vaejovis mexicanus [36,63], BmKn2 and BmKb1 from
Mesobuthus martensii [87], Ctriporin from Chaerilus tricostatus [27],
Meucin 13 andMeucin 18 fromMesobuthus eupeus [29], StCT2 from
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corpiops tibetanus [10], TsAP-1 and TsAP-2 both from Tityus serru-
atus [31]. A recent comprehensive review on the different classes
f AMP found in the venom of several scorpion species can be
ound elsewhere [35]. Taken together, these examples indicate that
corpion venoms are rich resources for the study of antimicrobial
eptides.
The members of Buthidae scorpions are dangerous to humans;
o date, approximately 500 species have been identiﬁed, of which
5 can cause lethal accidents [60]. These animals have a wide
istribution around the globe: species of the genera Androctonus,
eiurus and Buthus are found in North Africa, Middle East and India,
enus Parabuthus is found in South Africa and genus Tityus in South
merica, especially Brazil [73]. In Brazil, studies on the chemical
roperties of scorpion venoms have been performed more fre-
uently in T. serrulatus, T. bahiensis and T. fasciolatus [5,39]. In
ontrast, the venom of Tityus stigmurus was not yet explored as
n arsenal of toxins with potential biotechnological applications.
ur group has previously reported the identiﬁcation of a transcript
ncoding an antimicrobial peptide (AMP) from T. stigmurus, which
as the most abundant transcript in the venom gland [3]. In the
resent study, this peptide (herein named Stigmurin) had its struc-
ure evaluated in silico and by circular dichroism, and its biological
ctivities investigated against different microorganisms and in dif-
erent mammal cell lines in vitro.
aterials and methods
ioinformatic and phylogenetic analyses
The complete nucleotide sequence TSTI0001C selected from
he full length cDNA library [3] was analyzed by ORF-Finder [70].
ultiple alignments were performed with CLUSTAL X [44]. Puta-
ive signal peptide, propeptide and mature peptide were predicted
sing SignalP v4.0 [57] and ProP 1.0 [24]. The amino acid sequence
as subjected to a similarity search in the database of the National
enter for Biotechnology Information (NCBI) using BLASTp [4].
The phylogenetic analysis was performed using AMP
equences with known three-dimensional structure,
btained from the Antimicrobial Peptide Database (APD;
ttp://aps.unmc.edu/AP/main.php) [78]. Selected sequences
ere aligned using the programs MAFFT [41] and MUSCLE [25].
best-ﬁt adjustment of the amino acids substitution model was
erformed using the ProtTest tool [20]. The dendrogram was
alculated based on a Bayesian analysis using the BEAST tool
23]. Inferences were conducted in two independent runs with
our simultaneous chains each, and ﬁxed WAG model, allowing
amma distributed rates among sites. Each Markov Chain was
nitiated with a random tree, ran for 106 generations, and sampled
very 100 generations. Consensus tree was estimated following
discarded burn-in of 1,000,000 trees. The convergence of the
imultaneous runs was assessed using the Tracer tool v.1.5 [22],
o evaluate the statistic support and robustness of the Bayesian
nalysis. Generated trees were edited in the software FigTree
http://tree.bio.ed.ac.uk/software/ﬁgtree/) [62].
eptide modeling
Stigmurin modeling was performed using I-TASSER [68], and 5
odels were generated. The structures were validated by checking
amachandran plots, C derivation, clash scores, rotamers, back-
one bonds and backbone angles [12]. The models were analyzed
nd sortedby score values, andpdbﬁleswere visualizedusingUSFC
himera software [83]. The top three models were submitted to a
olecular dynamics analysis.es 68 (2015) 3–10
Models reﬁnement
Molecular dynamics simulations were performed to optimize
the obtained models. All simulations were performed in explicit
water (TIP3P) or 2,2,2-triﬂuoroethanol (TFE) 70%, using GROMACS
[71]. Simulation package and AMBER 99SB-ILDN force ﬁeld were
used [45]. The protonation state of the protein residues at pH 7.0
was determined by PROPKA web server [53]. The simulation time
step was 0.5s; the minimum distance between any atom of the
protein and the box wall was 1.2nm. Coulomb and van der Waals
interactionswithin a shorter-range cutoff of 1.0nmwere computed
every time step. Particle Mesh Ewald was employed to minimize
the effects of truncating the electrostatic interactions beyond the
1.2nm long-range cutoff. Covalent bonds in the protein were con-
strained using the LINCS algorithm [37].
Circular dichroism (CD)
Far-UV spectra of the peptide were recorded at 25 ◦C in water,
TFE 20%, 50% or 70% (v/v) or sodium dodecyl sulfate (SDS), using
0.1 cm pathlength quartz cuvette in a Jasco J-810 spectropolarime-
ter (Jasco, Tokyo, Japan) with Peltier-type temperature controller.
Each spectrum corresponds to an average of ﬁve scans taken from
182 to260nm, at a scan rate of 50nm/min [77,80]. Secondary struc-
ture of Stigmurin was determined by deconvoluting CD data using
CONTIN/LL [72], CDSSTR [14] and K2D [6] algorithms. We have also
used CAPITO web-server [81] to verify the results.
Peptide synthesis
Mature peptide (without both, signal peptide and propeptide),
herein named Stigmurin, was synthesized in its amidated form by
Invitrogen Life Technologies, USA, using FMOC solid-phase tech-
nology [11,49]. C-terminal amidation was selected based on the
presence, in the complete translated sequence, of a highly con-
served post-translational processing signal (Gly-Arg-Arg-Lys), of
which the proteolytic cleavage typically precedes the amidation of
the adjacent residue in themature peptide, as described previously
for several similar scorpionpeptides [17,31,42,86,88]. Thesynthetic
peptide was puriﬁed by reverse-phase HPLC (>90% purity) and its
molecular weight was conﬁrmed by mass spectrometry performed
by the supplier (Supplementary Fig. 1).
Supplementary Fig. 1 related to this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.
peptides.2015.03.003.
Microorganism strains and in vitro antimicrobial assay
For antimicrobial assays, the following strains were used:
Staphylococcus aureus (ATCC 29213), Escherichia coli (ATCC 25922),
methicillin-resistant Staphylococcus aureus MRSA (ATCC 33591),
Candida albicans (ATCC 90028), Candida krusei (ATCC 6258) and
Candida glabrata (ATCC 90030).
Minimal inhibitory concentration (MIC) was determined by
broth microdilution method in Mueller Hinton Broth (MHB), fol-
lowing the guidelines of the Clinical and Laboratory Standards
Institute CLSI [13], with small variations as indicated below.
Inocules were prepared at 1×105 colony forming units per
milliliter (CFU/mL) for bacteria and to 1×104 CFU/mL for yeasts.
One hundred microliters of the bacterial suspension and 100l of
serially diluted Stigmurin were added to each well in microtiter
plates, to a ﬁnal peptide concentration of 1.1–139.5M. The plates
were incubated at 35 ◦C for 24h (bacteria) or at 30 ◦C for 48h
(yeasts) with continuous shaking in a humidiﬁed atmosphere. Pos-
itive growth controls were inoculated as describe above, without
addition of peptide. Sterile MHB was used as negative control. The
Peptides 68 (2015) 3–10 5
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Fig. 1. Nucleotide and translated amino acid sequences of the cDNA clone encoding
Stigmurin precursor, as analyzed by ORF-Finder. Predicted amino acid sequence
is shown below corresponding codons. Putative signal peptide (bold), propeptide
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ICwas deﬁned as the lowest concentration able to preventmicro-
ial growth, based on optical density (absorbance at 550nm) [82].
emolysis assay
Hemolytic activity was assessed by incubating a suspension of
ealthy human donor erythrocytes with increasing concentrations
f synthetic peptide. Cells were ﬁrst washed three times by cen-
rifugation at 8000× g for 5min in 1X PBS, pH 7.4 [52,58], then
ncubated with Stigmurin (1.1–139.5M) at 37 ◦C for 180min.
ptical density (absorbance at 540nm) of supernatants was
ecorded using a plate reader (Epoch-Biotek, Winooski, VT, USA).
ytotoxicity assay
The cytotoxicity of the synthetic peptide was evaluated in
iHa cells (human cervical cancer cell line) and Vero E6 cells
African green monkey kidney epithelial cell line). Cell viability
as measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetra-
olium bromide (MTT) assay (Sigma–Aldrich, Germany). Conﬂuent
ell-monolayers contained in 96-well plates were incubated with
erially diluted Stigmurin (2.17–279M) in RPMI-1640 for SiHa
ells, or Leibovitz (L-15) for Vero E6 cells, at 37 ◦C for 24h. Then,
0L of MTT (1mg/mL) was added to each well and further incu-
ated for 4h at 37 ◦C. Supernatants were removed and replaced
y 100L of dimethyl sulfoxide (DMSO) to solubilize formazan
rystals [51], and absorbance was measured at 540nm. Peptide
oncentration necessary to reduce cell viability in 50% (IC50) was
alculated by comparison with untreated cells.
tatistical analysis
For the interpretation of bioassays,multiple-group comparisons
ere evaluated by analysis of variance (ANOVA) using Graph Pad
rism software (Version 5.00, Graph Pad, San Diego, CA, USA). Dif-
erences were considered signiﬁcant when p<0.05.
esults
ioinformatic and phylogenetic analyses
From the cDNA library obtained from T. stigmurus venom
lands [3], the clone TSTI0001C was isolated and identiﬁed, cod-
ng for a mature protein with 73 amino acid residues [GenBank:
K483709], named Stigmurin. The protein sequence shows a 22
mino acids-long signal peptide, and propeptide starting with the
ighly conserved post-translational processing signal: Gly-Arg-
rg-Lys-Arg (GRRKR), and 29 amino acids preceding the mature
rotein of 17 amino acids (Fig. 1).
ig. 2. Alignment of Stigmurin (GenBank: JK483709) with that of known antimicrobial
cale indicates the residues’ degree of conservation. Dashed line: signal peptide; stars: p
onor glycine residues; crosses: cleavage site for proprotein convertase; rectangle: prope
5G8B3.1: antimicrobial peptide clone 6 from T. costatus; Q5G8B4.1: antimicrobial pep
aerin-like peptide from Mesobuthus eupeus; AAW23032.1: toxin peptide from M. marte
ychas mucronatus; C7B247.1: Imcroporin from Isometrus maculatus.(italics) and mature peptide (dark gray box) were predicted using SignalP v4.0 and
ProP 1.0. The conserved propetide convertase cleavage site is indicated in light gray
box.
Multiple sequence alignmentwith peptides retrieved fromGen-
Bank (Fig. 2) showed high similarity between Stigmurin and PAMs
of different scorpion species, all exhibiting experimentally proved
in vitro antimicrobial activity [2,8,17,21,31,47,88]. Several amino
acid residues are observed in conserved positions of these peptides,
especially in mature toxin region. Probably all aligned sequences
undergo post-translational modiﬁcation, given the presence of the
signal peptide, propeptide and cleavage site [31]. Interestingly,
the phylogenetic analysis (Fig. 3) demonstrated that Stigmurin,
alongwith the scorpionpeptidesMucroporinandBmkb1, exhibited
signiﬁcant sequence similarity (as well as an evolutive prox-
imity) to phylloseptins, a family of antimicrobial peptides from
South/Central American Phyllomedusinae frog skin [43,61].
According to structural modeling, it was observed that Stig-
murin shows alpha-helical conformation (Fig. 4A). The stability of
the secondary structure depends on the environment by which it
is surrounded; this is supported by two simulation experiments
where the peptide changed from alpha-helix structure to a beta-
sheet conformation when in water, whereas it assumed a random
coil structure when the simulation was performed in TFE 70%
(Fig. 4B and C, and Supplementary videos 1 and 2).
Supplementary Videos 1 and 2 related to this article can
be found, in the online version, at http://dx.doi.org/10.1016/j.
peptides.2015.03.003.
Secondary structure evaluated by CD spectroscopyThe CD analysis of synthetic Stigmurin in aqueous solution
showed a typical spectrum of disordered structure. When 20%
TFE was added to the system, the dichroic spectrum changed; in
peptides from scorpions by CLUSTAL X, indicating different peptide regions. Gray
robable active peptide; asterisks: C-terminal amidated lysine and adjacent amide
ptide. GenBank accession numbers are: S6CWV8.1: TsAP-1 from Tityus serrulatus;
tide clone 5 from T. costatus; S6D3A7.1: TsAP-2 from T. serrulatus; AGC92780.1:
nsii; G8YYA5.1: AamAP1 from Androctonus amoreuxi; B9UIY3.1: Mucroporin, from
6 E.T. de Melo et al. / Peptides 68 (2015) 3–10
Fig. 3. Phylogenetic analysis of Stigmurin and antimicrobial peptides with known secondary structure, obtained from multiple alignment using MAFFT program. Bayesian
analysis was performed in BEAST tool using ﬁxed WAG model. Posterior predictive p-values are shown in the nodes. Color code represent: red= scorpion AMPs;
blue = Stigmurin; green=phylloseptins, black =peptides from hylids. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of the article.)
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In vitro cytotoxicity
Stigmurin showed toxicity against SiHa cells, leading to 36%,
69% and 92% of non-viable cells after exposition to the peptide
Table 1
Minimum inhibitory concentrations (MIC) of synthetic Stigmurin peptide against
standard bacterial strains. Values represent mean± SD (n=3). **p<0.01 and
***p<0.001 compared to positive control.
Strains MIC (M± SD)
Gram-positive
Staphylococcus aureus (ATCC 29213) 8.68±1.1***
Methicillin-resistant S. aureus MRSA (ATCC 33591) 17.37±1.2***
Gram-negative
Escherichia coli (ATCC 25922) >139ig. 4. Modeled patterns of Stigmurin’s secondary structure (A) Stigmurin modeled
ydrophilic residues are shown in red and blue, respectively. Also, representative sn
v/v) TFE solution. Simulations were performed in GROMACS with 0.5-s time step
0% TFE, the deviation of the spectra from zero-value of ellip-
icity became more prominent, and the results were similar in
0% TFE, as well as in SDS above critical micelle concentration
CMC), a membrane–mimetic environment (Fig. 5A). The spectra
ere analyzed by deconvolution using four different approaches
6,14,72,81]. Fig. 5Bpresents theproportionof the sequenceassum-
ng alpha-helical, beta-sheet or random coil secondary structure in
he different environments, calculated as the mean of the values
ound by the four methods. The results show a general predomi-
ance of random coil and beta-sheet conformation.
ntimicrobial activity
Stigmurin was active against Gram-positive bacterial strains
taphylococcus aureus andMethicillin-resistant S. aureusMRSA, and
he yeasts C. albicans, C. krusei, and C. glabrata, but it was ineffec-
ive against Gram-negative E. coli (Table 1). Interestingly, Stigmurin
as found to possess low hemolytic activity (22%) at the highest
oncentration tested (139.5M), as shown in Fig. 6.io by I-TASSER, visualized using USFC Chimera software. Hydrophobic residues and
ts from the dynamics simulations are shown in (B) in explicit water and (C) in 70%
ting from full -helices and using AMBER 99SB-ILDN force ﬁeld.Yeasts
Candida albicans (ATCC 90028) 34.75±1.4***
C. krusei (ATCC 6258) 69.5±4.02**
C. glabrata (ATCC 90030) 69.5±2.83***
E.T. de Melo et al. / Peptides 68 (2015) 3–10 7
Fig. 5. Stigmurin evaluation by Far-UV circular dichroism. (A) CD spectra in water
(light gray), TFE 20% (dotted), 50% (dashed), and 70% (solid black), 20mM SDS
(dark gray). (B) Predominance of secondary structures according to deconvolution
data of CD spectra using different algorithms (CONTIN/LL, SELCON and K2D) and
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Fig. 6. Hemolytic activity of Stigmurin. Human red blood-cells were incubatedwith
serially diluted Stigmurin (1.1–139.5M), at 37 ◦C for 180min. The activity was
determined by measuring the absorbance at 540nm, using PBS and distilled water
as negative and positive lysis control, respectively. Percentage hemolysis was cal-
F
l
f
mAPITO server (CD Analysis and Plotting Tool). Values presented are mean± SD of
he percentages obtained by the four different methods, except in water, which was
erformed exclusively using CAPITO.
t concentrations of 69.8M, 139.5M and 279M, respectively
Fig. 7A). Cytotoxic effect it was also observed in Vero E6 cells,
here 57% and 89% of the cells were non-viable after incubation
ith Stigmurin at concentrations of 139.5M and 279M, respec-
ively (Fig. 7B). The IC50 parameter veriﬁes that viability reduction
as more prominent on human carcinoma lineage SiHa (IC50
18M), than on monkey epithelial cells Vero E6 (IC50 150M).
iscussion
The identiﬁcation and analysis of Stigmurin demonstrated that
his peptide has high sequence similarity to other non-disulﬁde-
ridged antimicrobial peptides [2,8,17,21,31,47,88]. Through
ultiple sequence alignment and phylogenetic analysis, it could be
oticed a signiﬁcant conservation of key amino acid residues that
ig. 7. Citotoxicity of Stigmurin. Dose–response curves of cell viability as measured by 3
ines SiHa (A) and Vero E6 (B). Cells were cultured in 96-well microtiter plates using RPM
or 24h. The activity was determined by measuring the absorbance at 540nm after add
ean± SD (n=3). Statistical signiﬁcance was analyzed using a paired t-test. *p<0.05, **pculated relative to the positive control (100%). Values represent mean± SD (n=3).
**p<0.01 compared to positive control.
are characteristic of antimicrobial peptides [73]. This observation is
consistent with the hypothesis that many AMPs are evolutionarily
related within the Scorpionidae taxon, having arisen from multi-
ple duplications of an ancestral gene [73,86]. The diversiﬁcation
of AMPs could then be part of an evolutionary strategy driven by
the rapid evolution of pathogens [67]. Furthermore, bioinformatic
analysis showed evidence that Stigmurin is a new AMP.
Structural analysis of Stigmurin by molecular dynamics and CD
showed that its structure differswhen in the presence ofwater, SDS
orTFE. These results suggest that itmayassumedifferent conforma-
tions depending on the environment, which is a common behavior
in AMPs [74]. It is essential to highlight that, according to CD anal-
ysis, Stigmurin exhibited a more regular secondary structure when
in contact with TFE or SDS. TFE diminishes the peptide interac-
tion with the solvent and favors intramolecular interactions, thus
increasing the chance of secondary structure conformation (in this
work, mainly -sheet) [65]. Stigmurin presented a different struc-
ture in the presence of water, mostly random coil. Furthermore,
the contact with a micellar solution led to a conformational shift in
Stigmurin’s structure, indicating that it may interact with micelles,
which mimic membranes [74]. This suggests that the mechanism
of action of Stigmurin is through interaction with membranes,
which is very common among other AMPs already characterized
[33,40,65,74,85].
It is noticed a discrepancy between the homology models (all
alpha-helical structure, Fig. 4A) with the ﬁndings from dynamics
-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay in cell
I-1640 or L-15 media in the presence of serially diluted Stigmurin (2.17–279M)
ition of MTT for 4h and subsequent solubilization with DMSO. Values represent
<0.01 and ***p<0.001 compared to positive control.
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imulation (Fig. 4B and C) and experimental CD results (Fig. 5A and
). Altogether, the present study revealed that Stigmurin alters its
econdary structure according to the medium, which shows that
he residues canbe structuredorﬂexible in speciﬁc conditions, pos-
ibly having a functional signiﬁcance [33,34,74]. Another point to
e discussed is that themolecular dynamics simulation agreeswith
econvoluted CD results regarding the type of predominant struc-
ures, but not the tendency of variation in different media. This
ould derive from the deconvolution algorithms, which are opti-
ized for larger proteins rather than for small peptides [6,14,72],
r from issues to accurately represent the dielectric propertieswith
he force ﬁeld employed in the simulations [38]. Nevertheless, it
an be concluded that Stigmurin has an environment-dependent
onformation.
In this work we have demonstrated that Stigmurin, a novel
ntimicrobial peptide, possesses antimicrobial activity against
ram-positive bacteria, including antibiotic-resistant pathogens
MRSA), and fungi. Peptide TsAP-1 from T. serrulatus venom, a
ighly similar scorpion AMP (96% identity) from a closely related
pecies, presented poor antimicrobial activity (MIC>120M for S.
ureus, E. coli and C. albicans) when compared to Stigmurin [31].
oth peptides have the same net charge (+2 considering the C-
erminal amidation), and there areonly two residueswhichdiffer in
hematurepeptide sequences, exchangingPhe24andLeu34 inStig-
urin for a Leu and a Ser, respectively, in TsAP-1 [31]. It is possible
hat the different activity is a result of a decreased hydrophobicity
onferred by Ser to TsAP-1. Peptide hydrophobicity, togetherwith a
ositive net charge in an amphipathic arrangement, is considered a
ajor requirement for their antimicrobial activity [59]. In contrast,
espite a lower sequence similarity to Stigmurin (78%), peptide
sAP-2 from T. serrulatus has identical proportion of hydropho-
ic residues (10 out of 17) and presented a more similar activity,
ausing deleterious effects in Gram-positive bacterium S. aureus
evelopment, and in C. albicans, but being less effective against
ram-negative E. coli [31].
In fact, activity against Gram-positive bacteria with a weaker
ctivity against Gram-negative bacteria was also described for
ther non-disulﬁde-bridged peptides from scorpions such as Pan-
inin1 and -2, IsCT and IsCT2 [15,18,19]. Among these peptides,
sCT, IsCT2 and TsAP-2 present a conserved consensus sequence
X(0–5)IX3IX3IX4) where the three Ile residues seem to play an
mportant functional role [86]. This consensus is partially present
n Stigmurin and Pandinin2, where the second Ile residue is
ubstituted by other hydrophobic residues (Val and Phe, respec-
ively). Here again, hydrophobicity seems to be a key aspect in the
ntimicrobial activity of cationic peptides. The initial electrostatic
nteractionwith negatively charged surfacemolecules (e.g. teichoic
cids in the Gram-positive cell wall), and subsequent membrane
nsertion are important steps in the process of killing; however,
he mechanisms of action and the speciﬁc cellular targets can vary
mong peptides and among organisms for a given peptide [28].
urthermore, it is important to note that the differences in the cell
urface, or even differences in the absorption of the agent by each
ype of microorganism are other factors that can inﬂuence the MIC
alues [69].
Infections by multi-drug resistant pathogens such as MRSA
re reaching alarming numbers worldwide, frequently causing the
eath of hospital patients [55]. It is appreciated that themechanism
f action of AMPs, in contrast to most conventional antibiotics, is
ess prone to induce microbial resistance, and peptide antibiotics
avebeen considered valuable alternatives in the treatment of such
nfections [55]. Our results suggest that Stigmurin can be a can-
idate molecule for use in antimicrobial therapy. Furthermore, at
he concentration which Stigmurin has prominent antimicrobial
ctivity, its hemolytic activity is only mild, supporting the poten-
ial useof thismolecule for therapeutic purposes [88]. Interestingly,es 68 (2015) 3–10
Stigmurin combines a good antimicrobial activity with a fairly low
hemolytic activity, in contrast to the closely relatedpeptides from T.
serrulatus which are either poorly antimicrobial (TsAP-1) or highly
hemolytic (TsAP-2) [31].
There are fewer studies reporting AMPs activity against Candida
species, but it is believed that the mechanism of action is simi-
lar to that observed in bacteria [40]. The cell wall of yeasts is an
anionic surface characterized by its rigidity, being glucans (1,3-
 and 1,6-) the most abundant polysaccharides (around 60%),
followed by mannans. Chitin, the less abundant component, cor-
responds to approximately 1% of all saccharides present in the cell
wall [46]. Some scorpions AMPs tested against C. albicans yielded
similar results to those we found for Stigmurin, including: TSAP-
2 (MIC 10M) [31], Meucin-18 (MIC 24.1M) [29], and Ctriporin
(MIC 20g/mL) [27]. This data strengthens our results suggesting
that Stigmurin could be considered for the treatment of candidiasis.
The results on the cytotoxic activity of Stigmurin indicate a
possible differential toxicity toward tumor cells. This is in accor-
dance with observations by other researchers reporting variations
in sensitivity of different cell cultures to antitumor AMPs [7,79].
For instance, peptides present in the venom of the scorpion Tityus
discrepans were active against SKBR3 breast cancer cell line, having
negligible effect uponmonkey kidney cells (MA104) [16]. The exact
mechanism of toxicitywhich differs in different cell types is not yet
fully elucidated, but may be related to the negative charge of can-
cer cell membranes, due to increased expression of molecules with
anionic character, such as glycosylated mucins, sialylated ganglio-
sides, and heparin sulfate [30]. Furthermore, it has been reported
that cell intrinsic factors inﬂuence their sensitivity to toxic sub-
stances, including chemical biotransformation and binding forms,
characteristics of membrane permeability and surface determi-
nants, intracellular synthesis and mechanisms of adaptation and
recovery [9,64,84].
From T. serrulatus, peptide TsAP-2 showed cytotoxicity against
ﬁve different human cancer cell lines, with IC50 ranging from 4 to
15M,whereas TsAP-1 had a less effective antitumoral action [31].
This was in line with their antimicrobial activity; it is thus possible
that, like the effect upon microorganisms, Stigmurin’s antitumoral
potential is more similar to TsAP-2, despite a lower sequence simi-
larity, as discussed above. The IC50 values obtained in the high M
range for Stigmurin upon the two cell lines tested in the present
study are not per se indicators of an antitumoral activity; besides
potency, other parameters such asmaximumeffect and the slope of
the dose–response curve, should also be taken into account when
analyzing putative novel antitumoral drugs [26]. Further studies
on a wider panel of tumor cell lineages will be required to suggest
a possible anticancer potential for Stigmurin. Nevertheless, this is
to our knowledge the ﬁrst scientiﬁc evidence demonstrating the
effect of a component of T. stigmurus venom on cell viability of a
human cancer cell line.
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